arrow
T

Tori N. Yamamoto

National Cancer Institute
H指数:23
被引数:5,212

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer genes disfavoring T cell immunity identified via integrated systems approach
2022-08-015
OAAI
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
Nature
IF48.5
2021-09-150
PRE
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

SARS-CoV-2血清学测定的评估揭示了一系列测试性能

2020-08-27304
OAAI
Mg2+ regulation of kinase signaling and immune function
2019-06-1344
OAAI
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
2019-02-25129
OA
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
2017-12-07172
OAAI
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy
2015-12-14211
OA